Danaher Exceeds Q1 Expectations Amid Market Uncertainty, Driven by Bioprocessing and Diagnostics Growth
SHERIDAN, WYOMING – May 1, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology leader, reported first-quarter 2025 financial results that exceeded expectations across revenue, earnings, and cash flow, underscoring the strength of its diversified portfolio and operational excellence amid a dynamic macroeconomic environment.